118 related articles for article (PubMed ID: 6755207)
1. The treatment of acute lymphoblastic leukaemia (ALL) in childhood, UKALL III: the effects of added cytosine arabinoside and/or asparaginase, and a comparison of continuous or discontinuous mercaptopurine in regimens for standard risk ALL.
Med Pediatr Oncol; 1982; 10(5):501-10. PubMed ID: 6755207
[TBL] [Abstract][Full Text] [Related]
2. Remission induction with cytosine arabinoside and L-asparaginase in acute lymphoblastic leukaemia.
McElwain TJ; Hardisty RM
Br Med J; 1969 Dec; 4(5683):596-8. PubMed ID: 5261071
[TBL] [Abstract][Full Text] [Related]
3. Duration of chemotherapy in childhood acute lymphoblastic leukaemia. The Medical Research Council's Working Party on Leukaemia in Childhood.
Med Pediatr Oncol; 1982; 10(5):511-20. PubMed ID: 6755208
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL).
Chessells JM; Cornbleet M
Med Pediatr Oncol; 1979; 6(4):359-65. PubMed ID: 289904
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group.
Miller DR; Leikin S; Albo V; Sather H; Karon M; Hammond D
Cancer; 1983 Mar; 51(6):1041-9. PubMed ID: 6336986
[No Abstract] [Full Text] [Related]
6. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
Chessells JM; Durrant J; Hardy RM; Richards S
J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
[TBL] [Abstract][Full Text] [Related]
7. Improvement in treatment for children with acute lymphoblastic leukaemia. The Medical Research Council UKALL trials, 1972-84. Report to the Council by the Working Party on Leukaemia in Childhood.
Lancet; 1986 Feb; 1(8478):408-11. PubMed ID: 2868339
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
van Eys J; Berry D; Crist W; Doering E; Fernbach D; Pullen J; Shuster J; Wharam M
Cancer; 1989 Jan; 63(1):23-9. PubMed ID: 2910421
[TBL] [Abstract][Full Text] [Related]
10. [Acute lymphoblastic leukemia in children. Long survivals obtained with protocols C2-72 and D-74 (1972-1977)].
Ortega JJ; Javier G; Montagut JM; Torán N
An Esp Pediatr; 1986 Feb; 24(2):87-97. PubMed ID: 3516041
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and occult testicular relapses in children with acute lymphoblastic leukemia. Treated with the D.74 and pethema 7/78 protocols].
Ortega JJ; Javier G; Torán N
An Esp Pediatr; 1984 Sep; 21(3):199-214. PubMed ID: 6594962
[TBL] [Abstract][Full Text] [Related]
12. Sequential high-dose cytosine arabinoside and L-asparaginase in childhood leukemia in relapse.
Ettinger LJ; Biener R; Finklestein JZ; Kamalakar P; Jones GR; Avramis VI; Holcenberg JS
Semin Oncol; 1985 Jun; 12(2 Suppl 3):155-9. PubMed ID: 3859930
[No Abstract] [Full Text] [Related]
13. The role played by radiotherapy in the UKALL III series of trials for the treatment of acute lymphoblastic leukaemia in childhood.
Hathaway FK
Radiography; 1974 Nov; 40(479):255-8. PubMed ID: 4618915
[No Abstract] [Full Text] [Related]
14. Therapy of acute leukemia with drug combinations which include asparaginase.
Leventhal BG; Henderson ES
Cancer; 1971 Oct; 28(4):825-9. PubMed ID: 5286445
[No Abstract] [Full Text] [Related]
15. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
Rivera G; Dahl GV; Bowman WP; Avery TL; Wood A; Aur RJ
Cancer; 1980 Oct; 46(8):1727-30. PubMed ID: 6932995
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials.
Cáp J; Koza I; Misíková Z; Foltinová A; Strbáková E
Neoplasma; 1983; 30(1):81-92. PubMed ID: 6339961
[TBL] [Abstract][Full Text] [Related]
17. Testicular histology after combination chemotherapy in childhood for acute lymphoblastic leukaemia.
Lendon M; Hann IM; Palmer MK; Shalet SM; Jones PH
Lancet; 1978 Aug; 2(8087):439-41. PubMed ID: 79804
[TBL] [Abstract][Full Text] [Related]
18. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
[TBL] [Abstract][Full Text] [Related]
19. Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance.
Schaison G; Leverger G; Bancillon A; Marty M; Olive D; Cornu G; Griscelli C; Lemerle S; Harousseau JL; Bonnet M
Haematol Blood Transfus; 1987; 30():461-5. PubMed ID: 3305213
[No Abstract] [Full Text] [Related]
20. Leukemia relapse in long-term survivors of acute leukemia.
Kawashima K; Nagura E; Yamada K; Hamajima N
Cancer; 1985 Jul; 56(1):88-94. PubMed ID: 3859360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
